Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.

NCT01262586 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Type II Diabetes Mellitus

Interventions

DRUG: Vildagliptin
DRUG: Glimepiride

Sponsor

Novartis Pharmaceuticals